Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.35 USD | +2.76% | +1.52% | +50.90% |
Apr. 17 | North American Morning Briefing : Stock Futures -2- | DJ |
Apr. 16 | NexImmune, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Financials (USD)
Sales 2022 | - | Sales 2023 | - | Capitalization | 2.35M |
---|---|---|---|---|---|
Net income 2022 | -62M | Net income 2023 | -32M | EV / Sales 2022 | - |
Net cash position 2022 | 33.62M | Net cash position 2023 | 3.13M | EV / Sales 2023 | - |
P/E ratio 2022 |
-0.09
x | P/E ratio 2023 |
-0.07
x | Employees | 6 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 79.29% |
1 day | +2.76% | ||
1 week | +1.52% | ||
Current month | -40.29% | ||
1 month | -41.74% | ||
3 months | -34.82% | ||
6 months | -21.73% | ||
Current year | +50.90% |
Managers | Title | Age | Since |
---|---|---|---|
Kristi Jones
CEO | Chief Executive Officer | 60 | 17-05-31 |
Mathias Oelke
FOU | Founder | 56 | 11-06-06 |
Tonya Catterton
CMP | Compliance Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Sol Barer
CHM | Chairman | 76 | 19-12-15 |
Zheng Bin Yao
BRD | Director/Board Member | 58 | 16-12-31 |
Alan S. Roemer
BRD | Director/Board Member | 54 | 17-01-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 3.35 | +2.76% | 3 982 |
24-04-24 | 3.26 | -4.96% | 12,753 |
24-04-23 | 3.43 | -5.90% | 6,785 |
24-04-22 | 3.645 | +4.44% | 45,019 |
24-04-19 | 3.49 | +5.76% | 22,864 |
Delayed Quote Nasdaq, April 25, 2024 at 10:14 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+50.90% | 4.47M | |
-2.77% | 104B | |
+0.74% | 97.42B | |
+1.37% | 22.2B | |
-18.07% | 21.23B | |
-10.67% | 18.33B | |
-42.33% | 16.35B | |
-18.11% | 15.06B | |
+5.04% | 13.98B | |
+27.88% | 11.66B |
- Stock Market
- Equities
- NEXI Stock